• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Amgen sues Samsung biotech unit over bone drug copies

cafead

Administrator
Staff member
  • cafead   Aug 13, 2024 at 11:22: PM
via Amgen (AMGN.O) has sued Samsung's biologics unit (207940.KS) in New Jersey federal court over its proposed biosimilar versions of Amgen's blockbuster bone drugs Prolia and Xgeva.

article source
 

<